The Marqués de Valdecilla University Hospital held a theoretical‑practical course focused on the management of multiple myeloma and innovative anti‑BCMA immunotherapy strategies, bringing together Hematology specialists to address the latest advances in diagnosis, treatment, and clinical practice.
Organized by the hospital’s Hematology and Hemotherapy Department, the training program aimed primarily to update knowledge on one of the most complex hematologic neoplasms, as well as to promote the exchange of experiences among healthcare professionals.
During the first session, participants explored key aspects such as the diagnosis and monitoring of multiple myeloma, the management of transplant‑eligible and non‑eligible patients, and therapeutic strategies for relapse. New lines of anti‑BCMA immunotherapy were also analyzed, highlighting their role in treatment sequencing.
The program also included content related to care organization, such as the implementation of advanced therapy units, clinical trial management, and coordination with services like Home Hospitalization, reflecting the hospital’s own experience. In addition, attendees visited the hospital facilities and its Clinical Trials Unit, reinforcing the practical nature of the training.
The second session focused on applied clinical management through the resolution of practical cases in the Valdecilla Virtual Hospital environment, allowing participants to face real‑world situations related to the administration of immunotherapy and the management of potential complications.
The course featured the participation of experts from various fields, strengthening the position of the Marqués de Valdecilla University Hospital as a benchmark in specialized training and in the development of new therapeutic strategies in hematology.
This initiative underscores the hospital’s commitment to clinical excellence, innovation, and the continuous training of healthcare professionals—key elements for improving care for patients with multiple myeloma and other monoclonal gammopathies.
